 |
October 2003, Orlando Florida.
SurgiLight,
Inc (SRGL.OB) announced today that its Laser Presbyopia Reversal
Procedure (LAPR) had been featured in this months edition
of the Video Journal of Cataract and Refractive Surgery in
an issue entitled, “The Surgical Assualt on Presbyopia.”
This video reviews the state-of-the-art of all the current
surgical Presbyopia procedures. Spencer Thornton, M.D., who
is well known for his pioneering work in the field, provided
introductions of each technique. Dr. Thornton has also lectured
for SurgiLight in that past, despite his development of a
competing implant, because he believes the “SurgiLight
technology holds real promise.”
The video
segment features a surgical segment showing the LAPR procedure
being performed by Dr. Sandra Belmont of Cornell University
as well as several interviews on the technique and clinical
outcomes. The dialogue includes results of from the first
30 patients in the U.S. clinical trial in which 93% of patients
can read at J3 or better, i.e. can read a newspaper without
glasses. There were no significant complications in the first
study.
This media release may contain
forward-looking statements regarding but not limited to market
potential, distributor success, market size, international
approvals, FDA clearances, clinical studies and results of
those studies, marketing, future events and performance of
SurgiLight, which involve risks and uncertainties that could
materially affect actual results. Investors should refer to
documents that SurgiLight files with the SEC for a description
of certain factors that could cause actual results to vary
from current expectations and the forward-looking statements
contained in this media release.
Keywords:
surgilight, surgilight.com, SurgiLight, SurgiLight Inc.,Surgi
Light, OptiVision, presbyopia, laser presbyopia reversal,
LAPR, refractive surgery, accomodation, ophthalmology, new
trends in ophthalmology, laser, ophthalmology laster, erbium
yag, YAG, glaucoma.
|
|
|
Disclaimer:
All material herein is information supplied by the company or
other sources believed to be reliable. The information contained
herein is not guaranteed by TheNewsGate.com to be accurate,
and should not be considered to be all-inclusive. The companies
that are discussed in this profile have approved the statements
made in this profile. This profile contains forward-looking
statements that involve risks and uncertainties. Statements
in this press release about the company's future expectations,
including: development of licensing and branding and all other
statements in this release, other than historical facts, are
"forward-looking statements" within the meaning of
section 27A of the Securities Act of 1933, section 21E of the
Securities Act of 1934, as that term is defined in the Private
Securities Reform Act of 1995. It is important to note that
actual results and ultimate corporate actions could differ materially
from those in such forward looking statements. Such "forward-looking
statements" are subject to risks and uncertainties set
forth from time to time in the Company's SEC reports. This material
is for informational purposes only and should not be construed
as an offer or solicitation of an offer to buy or sell securities.
TheNewsGate.com is not a licensed broker, broker dealer, market
marker, investment advisor, analyst or underwriter. Please consult
a broker before purchasing or selling any securities viewed
on http://TheNewsGate.com/ TheNewsGate.com's affiliates, officers,
directors and employees may have bought or may buy the shares
discussed in this profile and may profit in the event those
shares rise in value. TheNewsGate.com does not and will not
offer any opinion as to when others should sell; each investor
must make that decision based on his or her judgment of the
market.
|
|
